Curcleve
by Leading Edge Health · Capsule
Supplement facts from the label of Curcleve by Leading Edge Health: Longvida 400 mg, Ginger 250 mg, AstraGin 50 mg.
Supplement Facts
| Ingredient | Per serving | % DV | Upper limit (adults) |
|---|---|---|---|
| Longvida (Turmeric Rhizome Extract) | 400 mg | — | — |
| Ginger (Gingerols) | 250 mg | — | — |
| AstraGin (Astragalus membranaceous, Panax notoginseng) | 50 mg | — | — |
Upper limits: NIH ODS Fact Sheets for Health Professionals. Compared only where the unit converts and the limit applies to the form on the label.
On the label
For: Adult (18 - 50 Years)
Claim types: All Other · Structure/Function
Formulation re: Other: The benefits of Curcleve High potency & maximum bioavailability
Formula re: Contains: Formulated with Longvida Optimized Curcumin, Curcleve delivers up to 285 times greater bioavailability and lasts seven times longer than standard curcumin. Curcleve also contains AstraGin, a proprietary astragalus and ginseng formulation that greatly increases the absorption of peptides, amino acids and nutrients. Used daily, Curcleve can help decrease inflammation, improve gut health, reduce pain
FDA Disclaimer Statement: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Precautions re: All Other: Do not use if tamper-evident seal is missing or broken.
Formula re: Contains: Longvida Optimized Curcumin
Suggested/Recommended/Usage/Directions: Suggested use: Take 1 capsule daily.
This page repeats what the label says and the official upper limits for healthy adults. It is not medical advice: ask a doctor, pharmacist or registered dietitian about your own intake, especially if you are pregnant, take medicines or have a health condition.
Label data: NIH Office of Dietary Supplements, Dietary Supplement Label Database (dsld.od.nih.gov), public domain. Upper limits: NIH ODS Fact Sheets for Health Professionals (values from the Institute of Medicine, Food and Nutrition Board).